Monitoring lymphoma patients after therapy
Roschewski, M.; Roschewski, M.
Clinical Advances in Hematology and Oncology H&o 13(5): 277-279
2015
ISSN/ISBN: 1543-0790 PMID: 26352768 Document Number: 685736
Document emailed within 1 workday
Related Documents
Cremerius, U.; Fabry, U.; Kröll, U.; Zimny, M.; Neuerburg, J.; Osieka, R.; Büll, U. 1999: Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients Nuklearmedizin. Nuclear Medicine 38(1): 24-30Rauhala, A.; Rantalaiho, V.; Almqvist, A.; Putkonen, M. 1995: Serum thymidine kinase in the monitoring of lymphoma patients Duodecim; Laaketieteellinen Aikakauskirja 111(5): 428-434
Masada, T.; Matsumoto, Y.; Kawai, N.; Tamiya, T.; Nagao, S. 2004: Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases No Shinkei Geka. Neurological Surgery 32(8): 859-864
Von Euler, H.P.; Rivera, P.; Aronsson, A.-C.; Bengtsson, C.; Hansson, L.-O.; Eriksson, S.K. 2009: Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay International Journal of Oncology 34(2): 505-510
Masaki, N.; Ikeda, H.; Hayabuchi, N.; Niibe, H.; Kaneta, H.; Morita, K.; Horiuchi, J.; Watanabe, S. 1988: Results of radiation therapy of stage I-II non-Hodgkin's lymphoma localized in the head and neck--a report of the Japanese Lymphoma Radiation Therapy Study Group Gan no Rinsho. Japan Journal of Cancer Clinics 34(5): 581-588
Masaki, N.; Ikeda, H.; Kaneta, K.; Morita, K.; Niibe, H.; Watanabe, S.; Hayabuchi, N.; Horiuchi, J. 1988: Results of radiation therapy of stage II non-Hodgkin's lymphoma of the Waldeyer's ring: a report of the Japanese Lymphoma Radiation Therapy Study Group Gan no Rinsho. Japan Journal of Cancer Clinics 34(5): 612-618
Kaneta, K.; Kawabata, K.; Hayabuchi, N.; Masaki, N.; Morita, K.; Horiuchi, J.; Niibe, H.; Watanabe, S. 1988: Results of radiation therapy of stage i and Ii nodal non-Hodgkin's lymphoma originated in the cervical lymph nodes--a study of the Japan Lymphoma Radiation Therapy Study Group Gan no Rinsho. Japan Journal of Cancer Clinics 34(5): 644-650
Kravchenko, S.K.; Bariakh, E.A.; Zamiatina, V.I.; Perestoronina, T.N.; Fink, O.S.; Gubkin, A.V.; Egorova, E.K.; Zvonkov, E.E.; Iliushkina, E.A.; Krasil'nikova, B.B.; Morozova, A.K.; Vorob'ev, I.A.; Kaplanskaia, I.B.; Kliasova, G.A.; Obukhova, T.N.; Kremenetskaia, A.M.; Vorob'ev, A.I. 2008: High-dose therapy of Burkitt's lymphoma in patients over 40 years of age Terapevticheskii Arkhiv 80(7): 9-18
Hasic, S.; Arnautovic, A.; Jovic, S.; Halilbasic, A.; Mazalovic, E. 2011: The role of predictor factors in patients with non Hodgkin lymphoma in relation to the applied therapy Medicinski Arhiv 65(2): 73-77
Janula, J.; Titzová, I. 1989: Monitoring and therapy of patients with diabetic retinopathy at the Eye Clinic in Brno Ceskoslovenska Oftalmologie 45(2): 91-94
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Zinner, S.H.; Blaser, J.; Gaya, H. 1986: Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients American Journal of Medicine 80(5c): 59-63
Baiocchi, O.C.G.; Colleoni, G.W.B.; Navajas, E.V.; Duarte, L.Claudio.C.; Alves, A.C.; Andrade, A.Lucia.S.S.; Kerbauy, J.; Oliveira, J.Salvador.R. 2002: Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma Acta Oncologica 41(2): 192-196
Eckert, S. 1999: Blood pressure self-monitoring supplements diagnosis and therapy. advantages over occasional monitoring Fortschritte der Medizin 117(5): 39-40
Pilas, V.; Bilić, A.; Vranjković, S. 1989: Cardiorespiratory monitoring in the diagnosis and therapy of patients with adult respiratory distress syndrome Lijecnicki Vjesnik 111(4-5): 135-139
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Tamura, K.; Araki, Y.; Seita, M. 1984: Treatment for advanced malignant lymphoma in patients with compromised bone marrow--a combination therapy using pepleomycin, vincristine and high-dose adrenocorticoids (POP regimen) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(12 Part 1): 2568-2572
Gordon, L.I. 2016: Precision Monitoring by Next-Generation Sequencing in Lymphoma: Circulating Tumor DNA as a new Biomarker Oncology 30(8): 745-746
Fürst, G.; Maurer, J.; Schlegel, J. 1995: Monitoring ototoxic side effects in streptomycin therapy of tuberculosis patients with transitory evoked otoacoustic emissions TEOAE Pneumologie 49(11): 590-595
Tweya, H.; Feldacker, C.; Ben-Smith, A.; Harries, A.D.; Komatsu, R.; Jahn, A.; Phiri, S.; Tassie, J.-M. 2012: Simplifying ART cohort monitoring: can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi? Bmc Health Services Research 12: 210